The PR Week: 5.7.2026 - Courtney Kasinger, Eli Lilly and Company

Why It Matters

The awards set benchmarks for effective healthcare communication, and Kasinger’s observations signal where pharma brands must invest to stay competitive and compliant.

Key Takeaways

• Kasinger chairs 2026 PRWeek Healthcare Awards jury
• Influencer collaborations now core to pharma campaigns
• Data‑rich storytelling drives measurable health outcomes
• Regulators push for transparent, patient‑first messaging
• Brands must blend creativity with compliance to win

Pulse Analysis

The PRWeek Healthcare Awards have become a bellwether for excellence in pharmaceutical and health‑care communications, and this year’s jury chair, Courtney Kasinger of Eli Lilly, offers a front‑row seat to the evolving landscape. In the podcast, Kasinger praised campaigns that blend scientific rigor with human stories, emphasizing that authenticity resonates more than ever with patients and providers. She underscored the growing influence of digital creators, noting that strategic partnerships with health‑focused influencers can amplify reach while maintaining credibility, a shift that mirrors broader marketing realignment toward community‑driven narratives.

Kasinger also highlighted the pivotal role of data‑driven storytelling. By leveraging real‑world evidence, patient outcomes, and analytics, marketers can craft messages that not only inform but also demonstrate tangible impact. This approach satisfies both audience expectations for relevance and regulator demands for substantiation. She pointed out that recent policy updates from the FDA and EMA encourage clearer disclosure of sponsorship and more transparent communication pathways, prompting brands to embed compliance into creative processes from the outset.

For pharma marketers, Kasinger’s takeaways translate into actionable imperatives: invest in influencer ecosystems that align with therapeutic areas, harness robust data to validate claims, and embed regulatory foresight into campaign design. Companies that master this triad of creativity, evidence, and compliance are poised to capture award recognition and, more importantly, build lasting trust with patients and clinicians. As the industry continues to digitize, the ability to tell compelling, compliant stories will define the next generation of healthcare brand leadership.